Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH

Watchlist Manager

Reviva Pharmaceuticals Holdings, Inc.

NASDAQ:RVPH

Watchlist

Dividends

Price: 1.7452 USD 6.41% Market Closed

Market Cap: 58.4m USD

Have any thoughts about
Reviva Pharmaceuticals Holdings, Inc.?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 1.7452 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

RVPH Alert

Reviva Pharmaceuticals Holdings, Inc.

1.7452

+0.1052 (+6.41%)

52 Week Range	0.644 5.52
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Reviva Pharmaceuticals Holdings, Inc.

What unique competitive advantages
does Reviva Pharmaceuticals Holdings, Inc. hold over its rivals?

What risks and challenges
does Reviva Pharmaceuticals Holdings, Inc. face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Reviva Pharmaceuticals Holdings, Inc..

What unique competitive advantages
does Reviva Pharmaceuticals Holdings, Inc. hold over its rivals?

What risks and challenges
does Reviva Pharmaceuticals Holdings, Inc. face in the near future?

Has there been any significant insider trading activity
in Reviva Pharmaceuticals Holdings, Inc. recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Reviva Pharmaceuticals Holdings, Inc..

Provide P/S
for Reviva Pharmaceuticals Holdings, Inc..

Provide P/E
for Reviva Pharmaceuticals Holdings, Inc..

Provide P/OCF
for Reviva Pharmaceuticals Holdings, Inc..

Provide P/FCFE
for Reviva Pharmaceuticals Holdings, Inc..

Provide P/B
for Reviva Pharmaceuticals Holdings, Inc..

Provide EV/S
for Reviva Pharmaceuticals Holdings, Inc..

Provide EV/GP
for Reviva Pharmaceuticals Holdings, Inc..

Provide EV/EBITDA
for Reviva Pharmaceuticals Holdings, Inc..

Provide EV/EBIT
for Reviva Pharmaceuticals Holdings, Inc..

Provide EV/OCF
for Reviva Pharmaceuticals Holdings, Inc..

Provide EV/FCFF
for Reviva Pharmaceuticals Holdings, Inc..

Provide EV/IC
for Reviva Pharmaceuticals Holdings, Inc..

Show me price targets
for Reviva Pharmaceuticals Holdings, Inc. made by professional analysts.

What are the Revenue projections
for Reviva Pharmaceuticals Holdings, Inc.?

How accurate were the past Revenue estimates
for Reviva Pharmaceuticals Holdings, Inc.?

What are the Net Income projections
for Reviva Pharmaceuticals Holdings, Inc.?

How accurate were the past Net Income estimates
for Reviva Pharmaceuticals Holdings, Inc.?

What are the EPS projections
for Reviva Pharmaceuticals Holdings, Inc.?

How accurate were the past EPS estimates
for Reviva Pharmaceuticals Holdings, Inc.?

What are the EBIT projections
for Reviva Pharmaceuticals Holdings, Inc.?

How accurate were the past EBIT estimates
for Reviva Pharmaceuticals Holdings, Inc.?

Compare the revenue forecasts
for Reviva Pharmaceuticals Holdings, Inc. with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Reviva Pharmaceuticals Holdings, Inc. and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Reviva Pharmaceuticals Holdings, Inc. against its competitors.

Analyze the profit margins
(gross, operating, and net) of Reviva Pharmaceuticals Holdings, Inc. compared to its peers.

Compare the P/E ratios
of Reviva Pharmaceuticals Holdings, Inc. against its peers.

Discuss the investment returns and shareholder value creation
comparing Reviva Pharmaceuticals Holdings, Inc. with its peers.

Analyze the financial leverage
of Reviva Pharmaceuticals Holdings, Inc. compared to its main competitors.

Show all profitability ratios
for Reviva Pharmaceuticals Holdings, Inc..

Provide ROE
for Reviva Pharmaceuticals Holdings, Inc..

Provide ROA
for Reviva Pharmaceuticals Holdings, Inc..

Provide ROIC
for Reviva Pharmaceuticals Holdings, Inc..

Provide ROCE
for Reviva Pharmaceuticals Holdings, Inc..

Provide Gross Margin
for Reviva Pharmaceuticals Holdings, Inc..

Provide Operating Margin
for Reviva Pharmaceuticals Holdings, Inc..

Provide Net Margin
for Reviva Pharmaceuticals Holdings, Inc..

Provide FCF Margin
for Reviva Pharmaceuticals Holdings, Inc..

Show all solvency ratios
for Reviva Pharmaceuticals Holdings, Inc..

Provide D/E Ratio
for Reviva Pharmaceuticals Holdings, Inc..

Provide D/A Ratio
for Reviva Pharmaceuticals Holdings, Inc..

Provide Interest Coverage Ratio
for Reviva Pharmaceuticals Holdings, Inc..

Provide Altman Z-Score Ratio
for Reviva Pharmaceuticals Holdings, Inc..

Provide Quick Ratio
for Reviva Pharmaceuticals Holdings, Inc..

Provide Current Ratio
for Reviva Pharmaceuticals Holdings, Inc..

Provide Cash Ratio
for Reviva Pharmaceuticals Holdings, Inc..

What is the historical Revenue growth
over the last 5 years for Reviva Pharmaceuticals Holdings, Inc.?

What is the historical Net Income growth
over the last 5 years for Reviva Pharmaceuticals Holdings, Inc.?

What is the current Free Cash Flow
of Reviva Pharmaceuticals Holdings, Inc.?

Discuss the annual earnings per share (EPS)
trend over the past five years for Reviva Pharmaceuticals Holdings, Inc..

Section:

Wall Street
Price Targets

RVPH Price Targets Summary
Reviva Pharmaceuticals Holdings, Inc.

Wall Street analysts forecast RVPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RVPH is 15.504 USD with a low forecast of 14.14 USD and a high forecast of 17.85 USD.

RVPH Average Forecast

Wall Street Target

15.504 USD

788% Upside

RVPH Highest Forecast

Wall Street Target

17.85 USD

923% Upside

Lowest

Price Target

14.14 USD

710% Upside

Average

Price Target

15.504 USD

788% Upside

Highest

Price Target

17.85 USD

923% Upside

Reviva Pharmaceuticals Holdings, Inc. Competitors:
Price Targets

KLBF

Kalbe Farma Tbk PT

28% Upside

DHG

Dhg Pharmaceutical Joint-Stock Co

5% Upside

CONCORDBIO

Concord Biotech Ltd

6% Downside

VIRP

Virbac SA

33% Upside

KLBF

Kalbe Farma Tbk PT

28% Upside

DHG

Dhg Pharmaceutical Joint-Stock Co

5% Upside

CONCORDBIO

Concord Biotech Ltd

6% Downside

VIRP

Virbac SA

33% Upside

XERS

Xeris Biopharma Holdings Inc

40% Upside

Revenue
Forecast

Revenue Estimate
Reviva Pharmaceuticals Holdings, Inc.

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Reviva Pharmaceuticals Holdings, Inc.

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Reviva Pharmaceuticals Holdings, Inc.

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

What is RVPH's stock price target?

Price Target
15.504 USD

According to Wall Street analysts, the average 1-year price target for RVPH is 15.504 USD with a low forecast of 14.14 USD and a high forecast of 17.85 USD.

	Franklin Covey Co NYSE:FC	36.87 USD 1.57%
	Mohawk Industries Inc NYSE:MHK	120.19 USD 0.54%
	Ardmore Shipping Corp NYSE:ASC	12.12 USD 2.02%
	ASGN Inc NYSE:ASGN	84.15 USD 0.71%
	Skyworks Solutions Inc NASDAQ:SWKS	90.35 USD 0.18%
	Weatherford International PLC NASDAQ:WFRD	68.07 USD 1.95%

	Johnson & Johnson NYSE:JNJ	145.85 USD 0.4%
	Bank of America Corp NYSE:BAC	44.38 USD 1.12%
	Mastercard Inc NYSE:MA	535.71 USD 1.28%
	Salesforce Inc NYSE:CRM	344.43 USD 0.45%
	Abbvie Inc NYSE:ABBV	180 USD 0.9%
	Home Depot Inc NYSE:HD	396.14 USD 0.94%

	Arista Networks Inc NYSE:ANET	114.65 USD 1.38%
	Visa Inc NYSE:V	320.65 USD 1.08%
	Texas Pacific Land Corp NYSE:TPL	1 161.2 USD 1.91%
	KLA Corp NASDAQ:KLAC	650.53 USD 0.39%
	Manhattan Associates Inc NASDAQ:MANH	282.27 USD 1.24%
	Pinduoduo Inc NASDAQ:PDD	99.72 USD -0.86%

	Salesforce Inc NYSE:CRM	344.43 USD 0.45%
	Accenture PLC NYSE:ACN	361.63 USD 0.8%
	ServiceNow Inc NYSE:NOW	1 105.56 USD 1.59%
	EOG Resources Inc NYSE:EOG	120.83 USD 0.82%
	Copart Inc NASDAQ:CPRT	59.11 USD 1.29%
	Applied Materials Inc NASDAQ:AMAT	168.37 USD 0.54%

Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH

Wall Street
Price Targets

RVPH Price Targets Summary
Reviva Pharmaceuticals Holdings, Inc.

Revenue
Forecast

Revenue Estimate
Reviva Pharmaceuticals Holdings, Inc.

Operating Income
Forecast

Operating Income Estimate
Reviva Pharmaceuticals Holdings, Inc.

Net Income
Forecast

Net Income Estimate
Reviva Pharmaceuticals Holdings, Inc.

See Also

What is RVPH's stock price target?

Price Target
15.504 USD

Company

Help

Tools

Stocks

Reviva Pharmaceuticals Holdings, Inc. NASDAQ:RVPH

Wall Street Price Targets

RVPH Price Targets Summary Reviva Pharmaceuticals Holdings, Inc.

Revenue Forecast

Revenue Estimate Reviva Pharmaceuticals Holdings, Inc.

Operating Income Forecast

Operating Income Estimate Reviva Pharmaceuticals Holdings, Inc.

Net Income Forecast

Net Income Estimate Reviva Pharmaceuticals Holdings, Inc.

See Also

What is RVPH's stock price target? Price Target 15.504 USD

Company

Help

Tools

Stocks

Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH

Wall Street
Price Targets

RVPH Price Targets Summary
Reviva Pharmaceuticals Holdings, Inc.

Revenue
Forecast

Revenue Estimate
Reviva Pharmaceuticals Holdings, Inc.

Operating Income
Forecast

Operating Income Estimate
Reviva Pharmaceuticals Holdings, Inc.

Net Income
Forecast

Net Income Estimate
Reviva Pharmaceuticals Holdings, Inc.

What is RVPH's stock price target?

Price Target
15.504 USD